Switching from Trintellix (Vortioxetine) 20mg to Cymbalta (Duloxetine)
For a patient on vortioxetine 20mg for over a year switching to duloxetine due to cost, reduce vortioxetine to 10mg for one week while simultaneously starting duloxetine 30mg, then discontinue vortioxetine after that single week. This approach balances minimizing discontinuation symptoms while avoiding prolonged overlap of two serotonergic agents.
Recommended Titration Strategy
Week 1: Cross-Titration
- Reduce vortioxetine from 20mg to 10mg daily
- Start duloxetine 30mg daily simultaneously
The FDA label for vortioxetine explicitly states that doses of 15mg/day or 20mg/day should be reduced to 10mg/day for one week prior to full discontinuation 1. Starting duloxetine at 30mg for one week before increasing to 60mg reduces nausea, the most common adverse effect 2.
Week 2 Onward: Complete Switch
- Discontinue vortioxetine completely
- Continue duloxetine 30mg for the second week
- Increase duloxetine to 60mg daily after week 2 (the standard therapeutic dose)
Rationale for This Approach
Why one week overlap is sufficient: Vortioxetine can be discontinued abruptly according to its FDA label, though tapering from higher doses is recommended 1. The medication has demonstrated minimal discontinuation symptoms in clinical trials 3. A one-week taper from 20mg to 10mg, followed by discontinuation, provides adequate protection against withdrawal while minimizing the duration of dual serotonergic agent exposure.
Why not extend to two weeks: While extending the overlap might seem safer, there's no evidence-based requirement for a longer cross-taper. The primary concern with combining two serotonergic antidepressants is serotonin syndrome risk 4. Keeping the overlap brief (one week) while using the lower vortioxetine dose (10mg) minimizes this risk. Additionally, vortioxetine has shown good tolerability with minimal discontinuation symptoms even with abrupt cessation 3.
Important Safety Considerations
Monitor for Serotonin Syndrome
During the one-week overlap period when both medications are present, watch for:
- Mental status changes (agitation, confusion)
- Autonomic hyperactivity (tachycardia, diaphoresis, hypertension)
- Neuromuscular abnormalities (tremor, hyperreflexia, clonus)
The risk is low at these doses but requires vigilance 4.
Duloxetine Titration Details
Starting duloxetine at 30mg once daily for one week before increasing to 60mg once daily significantly reduces nausea 2. Research confirms that slower titration improves tolerability—studies show discontinuation rates due to adverse events of only 3.6% with gradual titration versus 15% with faster escalation 5.
Expected Timeline for Therapeutic Effect
- Duloxetine typically requires 2-4 weeks to reach efficacious dosing 2
- Full antidepressant effect may not be evident until 4 weeks or later
- The patient has been stable on vortioxetine for over a year, so the brief transition period should be well-tolerated
Common Pitfalls to Avoid
Don't abruptly stop vortioxetine 20mg without tapering. While the FDA label states vortioxetine "can be discontinued abruptly," it specifically recommends reducing doses of 15-20mg to 10mg for one week first 1.
Don't start duloxetine at 60mg immediately. The evidence strongly supports starting at 30mg for one week to minimize gastrointestinal side effects, particularly nausea 2, 6.
Don't extend the overlap beyond one week without specific clinical indication. Prolonged dual serotonergic therapy increases serotonin syndrome risk without clear benefit 4.
Alternative Consideration
If the patient has a history of severe discontinuation symptoms with previous antidepressant switches, you could extend the vortioxetine 10mg overlap to two weeks while maintaining duloxetine 30mg. However, this is not the standard approach and should be reserved for patients with documented sensitivity to medication changes.